Brennan Mange
Brennan Mange publishes mostly in Economics and Econometrics, Education and Neurology, on topics such as Statistical Methods in Clinical Trials, Health Systems, Economic Evaluations, Quality of Life and Chronic Lymphocytic Leukemia Research.
- World rank
- #5,577,054 of 7,710,434 ranked researchers
- Rank in United States
- #1,398,290 of 1,627,098
- Works
- 29
- Citations
- 255
- Citations per work
- 8.8
What does Brennan Mange research?
Brennan Mange's work is mostly in Medicine (19%), Economics, Econometrics and Finance (12%), Social Sciences (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1655.7%
- Health Sciences619.2%
- Medicine619.2%
- Social Sciences619.2%
- Physical Sciences25.9%
- Mathematics25.9%
- 1Economics and Econometrics12% of their works
- 2Education7% of their works
- 3Neurology7% of their works
- 4Statistics and Probability6% of their works
- 5Genetics6% of their works
- 6Pathology and Forensic Medicine6% of their works
Research topics
- Statistical Methods in Clinical Trials
- Health Systems, Economic Evaluations, Quality of Life
- Chronic Lymphocytic Leukemia Research
- Virus-based gene therapy research
- Herpesvirus Infections and Treatments
- Multiple Myeloma Research and Treatments
- Parkinson's Disease Mechanisms and Treatments
- Lymphoma Diagnosis and Treatment
Which keywords describe Brennan Mange's research?
The keywords of their largest research topics: Rituximab, Adaptive Designs, Cost-effectiveness Analysis, False Discovery Rate, Quality of Life, Chronic Lymphocytic Leukemia, Genomic Aberrations and a-Synuclein.
- Viral Vectors
- Lymphoma
- Herpesviruses
- Gene Therapy
- Classification
- Chronic Lymphocytic Leukemia
- False Discovery Rate
- Adaptive Designs
- Rituximab
- Cost-effectiveness Analysis
- Quality of Life
- Genomic Aberrations
- Diagnosis Criteria
- Herpes Zoster
- International Myeloma Working Group
- Parkinson's Disease
- a-Synuclein
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 17 words, with their numbers
- Rituximab52 topics
- Adaptive Designs41 topic
- Cost-effectiveness Analysis41 topic
- False Discovery Rate41 topic
- Quality of Life41 topic
- Chronic Lymphocytic Leukemia31 topic
- Genomic Aberrations31 topic
- Classification21 topic
- Diagnosis Criteria21 topic
- Gene Therapy21 topic
- Herpes Zoster21 topic
- Herpesviruses21 topic
- International Myeloma Working Group21 topic
- Lymphoma21 topic
- Parkinson's Disease21 topic
- Viral Vectors21 topic
- a-Synuclein21 topic
Where does Brennan Mange work?
Brennan Mange's main affiliation in the publication record is RTI Health Solutions, United States.
How many publications and citations does Brennan Mange have?
OpenAlex counts 29 works and 255 citations for Brennan Mange, an h-index of 11, ranking #5,577,054 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Brennan Mange. Posts are plain text and can be reported.